β¨ Medicines Consent Notices
NEW ZEALAND GAZETTE
No. 13
Product:
Nicotrol
Active Ingredient: Nicotine 0.625mg/h
Dosage Form: Transdermal patch, systemic effect
New Zealand Sponsor: Pharmacia Limited Company
Manufacturer: Pharmacia AB, Helsingborg, Sweden
Product:
Nicotrol
Active Ingredient: Nicotine 0.9375mg/h
Dosage Form: Transdermal patch, systemic effect
New Zealand Sponsor: Pharmacia Limited Company
Manufacturer: Pharmacia AB, Helsingborg, Sweden
Product:
NovoRapid NovoLet
Active Ingredient: Insulin aspart 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer: Novo Nordisk A/S, Copenhagen, Denmark
Product:
NovoRapid Penfill
Active Ingredient: Insulin aspart 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer: Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product:
NovoRapid
Active Ingredient: Insulin aspart 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer: Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Product:
Priorix
Active Ingredients:
- Measles vaccine, Schwarz strain 1,000CCID50
- Mumps virus, live attenuated, RIT 4385 5,012CCID50
- Rubella virus, Wistar RA27/3 strain 1,000CCID50
Dosage Form: Powder for injection
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturers: - GlaxoSmithKline Biologicals, Rixensart, Belgium
- GlaxoSmithKline Biologicals, Genval, Belgium
- Sachsisches Serumwerk Dresden, Dresden, Germany
Product:
Varilrix Vaccine
Active Ingredient: Varicella vaccine 2,000PFU
Dosage Form: Solution for injection
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Biologicals, Rixensart, Belgium
Product:
Xenical
Active Ingredient: Orlistat 120mg
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers:
- F Hoffmann-La Roche Limited, Basel, Switzerland
- Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
- Roche Prodotti SpA, Segrate, Milan, Italy
Dated this 10th day of February 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go1012
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Actrapid Flexpen
Active Ingredient: Neutral insulin, human, pyr 100IU/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer: Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 13
Gazette.govt.nz —
NZ Gazette 2003, No 13
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of Changed Medicines
(continued from previous page)
π₯ Health & Social WelfareMedicines Act, Consent, Distribution, Changed Medicines
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare10 February 2003
Medicines Act, Consent, Distribution, New Medicines
- G. R. Boyd, Chief Advisor, Safety and Regulation